Fecobionics Evaluation of Biofeedback Therapy in Patients With Fecal Incontinence.
Fecobionics Evaluation of Biofeedback Therapy in Patients With Fecal Incontinence.
复制标题
DOI：
10.14309/ctg.0000000000000491
复制
发表时间：
2022-05-01
影响因子：
3.6
通讯作者：
中科院分区：
文献类型：
--
作者：
生物反馈疗法（BFT）是一种众所周知的功能性肛门直肠疾病治疗方法。通过 Fecobionics 测试以及传统技术、肛门直肠测压 (ARM) 和球囊排出测试 (BET) 监测 BFT 在大便失禁 (FI) 患者中的效果。对 12 名患者进行 8 周生物反馈训练前后的研究。获得大便失禁严重指数（FISI）评分。在袋子在直肠中膨胀直至有排便冲动之前，测量肛门静息压力和挤压压力。 Fecobionics 疏散期间进行了压力记录。 BFT 导致 FISI 评分降低 24%（P < 0.01）。七名患者被定性为有反应者。 BFT 期间肛门压力、排便冲动量和排便参数没有显着变化。对于ARM-BET，BFT 后的最大肛门挤压压力、排便冲动量和排出时间均低于BFT 前（P < 0.05）。对于 Fecobionics，排便量的变化（r = 0.74，P < 0.05）和排便指数的变化（r = 0.79，P < 0.01）与 FISI 评分的变化相关。 ARM-BET 参数均与 FISI 评分的变化无关。研究了 BFT 前的数据是否可以预测治疗成功。 Fecobionics 排出持续时间和排便指数预测结果（P < 0.05）。排便指数的敏感性为100%，特异性为72%。 ARM-BET 参数均未预测结果（所有 P > 0.2）。 Fecobionics 被用作监测 BFT 效果的工具，并被证明比传统技术更好地监测和预测 FISI 评分结果。
Biofeedback therapy (BFT) is a well-known treatment for functional anorectal disorders. The effect of BFT was monitored in fecal incontinence (FI) patients with the Fecobionics test and with the conventional technologies, anorectal manometry (ARM) and balloon expulsion test (BET). Studies were performed in 12 patients before and after 8 weeks of biofeedback training. The Fecal Incontinence Severity Index (FISI) score was obtained. Anal resting and squeeze pressures were measured before the bag was distended in the rectum until urge to defecate. Pressure recordings were made during Fecobionics evacuation. BFT resulted in 24% reduction in FISI scores (P < 0.01). Seven patients were characterized as responders. Anal pressures, the urge-to-defecate volume, and defecatory parameters did not change significantly during BFT. For ARM-BET, the maximum anal squeeze pressure, the urge-to-defecate volume, and the expulsion time were lower after BFT compared with those before BFT (P < 0.05). For Fecobionics, the change in urge volume (r = 0.74, P < 0.05) and the change in defecation index (r = 0.79, P < 0.01) were associated with the change in FISI score. None of the ARM-BET parameters were associated with the change in FISI score. It was studied whether any pre-BFT data could predict treatment success. The Fecobionics expulsion duration and the defecation index predicted the outcome (P < 0.05). The defecation index had a sensitivity of 100% and a specificity of 72%. None of the ARM-BET parameters predicted the outcome (all P > 0.2). Fecobionics was used as a tool to monitor the effect of BFT and proved better than conventional technologies for monitoring and predicting the outcome in the FISI score.